학술논문

Clinical and laboratory results from adeptTM 1, a phase 2 trial investigating the use of recombinant activated FVII analogue in congenital haemophilia patients with inhibitors: O-WE-029
Document Type
Academic Journal
Source
Journal of Thrombosis and Haemostasis. Jul 01, 2011 9 Suppl 2:512-513
Subject
Language
English
ISSN
1538-7933